Page 45 - Bse

Key challenge for new BSE chief: Keep NSE, rival he helped build, in check

Having spent nearly two decades at the country's largest bourse, Ramamurthy is among the early architects of NSE and understands all the cogs of the exchange wheel like only a few others

Uniparts India IPO: Here's why analysts recommend subscribing to the issue

Uniparts India IPO: Brokerages say the issue is reasonably valued given the company's robust financial profile and leading global market position in its core products

Sebi sets up three panels to push market reforms, ease of doing business

Experts to advise changes to framework around FPI, takeover code and social stock exchanges

Dharmaj Crop Guard IPO subscribed over 5x on strong retail, HNI interest

The two categories were subscribed around 7 times each; QIB was nearly half covered

Sebi gives nod to appointment of Ramamurthy as MD & CEO of BSE

Ramamurthy is currently the Chief Operating Officer-India at Bank of America

Drop in share of advisory assets in PMS funds during past 12 months

Overall PMS assets have been on the rise amid buoyant markets

Settlement scheme to be extended for 150 brokers from December 19

The scheme ends on January 19, 2023; terms and conditions will be made available on date of commencement

Mcap of 9 of top 10 firms climbs Rs 79,798 cr; TCS, Infosys biggest winners

Nine of the top 10 valued firms together added Rs 79,798.3 crore in market valuation last week, with IT majors Tata Consultancy Services (TCS) and Infosys emerging as the biggest winners. In the last week, the 30-share BSE Sensex climbed 630.16 points or 1 per cent. The barometer settled at 62,293.64, its fresh record closing high on Friday. Barring Adani Enterprises, all the 10 most valued firms including Reliance Industries, HDFC Bank, ICICI Bank and Hindustan Unilever Limited witnessed gains in their valuation. The market valuation of TCS jumped Rs 17,215.83 crore to Rs 12,39,997.62 crore. Infosys added Rs 15,946.6 crore taking its valuation to Rs 6,86,211.59 crore. The market valuation of Reliance Industries rallied Rs 13,192.48 crore to Rs 17,70,532.20 crore and that of Hindustan Unilever climbed Rs 12,535.07 crore to Rs 5,95,997.32 crore. ICICI Bank's market capitalisation (mcap) zoomed Rs 6,463.34 crore to Rs 6,48,362.25 crore and that of Bharti Airtel gained Rs 5,451.97 cr

Fewer active investors even as benchmark indices hit record highs

Market volatility and lacklustre 1-yr returns weigh on activity

Adani Enterprises to raise Rs 20,000 crore through follow-on public offer

The face value of each Adani Enterprises share would be Rs 1 each and the approval of the shareholders would be taken via postal ballot

Heavyweights do all the lifting in Nifty's record run, shows data

Since September 29, the index has added 1,666 points, of which 1,320 points - nearly 80 per cent - have been contributed by 10 stocks

Nifty, Sensex close at fresh lifetime highs after sharp late surge

US Fed minutes indicate slower pace of rate hikes, investors cheer

Nifty to reach 20,500 by end-2023, implying 12% price return: Goldman Sachs

Says India's 'superior' earnings growth appears to be priced in, sees 'modest' contraction in P/E multiples going ahead; stay overweight on banks, insurers, and investment cyclicals

T+1 settlement of all F&O stocks pushed to Jan 2023, transition at one go

However, the timeline issue for many FPIs remains, as the relaxation still compels them to book forex during non-market hours

Sebi extends one-time stock option settlement scheme by two months

Scheme provides a settlement opportunity to entities that have executed trade reversals in stock options from April 2014 to Sept 2015, and against whom adjudication proceedings are pending

Vedanta Group notifies third interim dividend of Rs 17.50 per share

Vedanta Group approved the third interim dividend of Rs 17.50 per share or 1750 per cent for the financial year 2022-23, on Tuesday November 2022

Paytm has lost over Rs 1 trillion in market cap since its issue

Paytm's m-cap, which was over Rs 1.38 trillion at the time of the launch of the IPO, has declined 77 per cent in just over a year to Rs 30,971 crore

Inflows in Tata Motors stock may surge as it replace Dr Reddy's in Sensex

Change effective from Dec 19, but adjustment will take place on Dec 16. After DRL's deletion, Sun Pharma will be the only healthcare stock in the index

Suven starts Phase 3 trial for first home-grown Alzheimer's drug

Clinical trial randomisation is the process of assigning patients by chance to groups that receive different treatments

Sebi asks IHH Healthcare to get Delhi HC nod for Fortis open offer

IHH indicated last week that it was ready to go ahead with the stalled open offer if the capital markets regulator allowed it